Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 276(47): 44323-30, 2001 Nov 23.
Article in English | MEDLINE | ID: mdl-11555645

ABSTRACT

Hypoxia-inducible factor (HIF) mediates a widespread transcriptional response to hypoxia through binding to cis-acting DNA sequences termed hypoxia response elements (HREs). Activity of the transcriptional complex is suppressed in the presence of oxygen by processes that include the targeting of HIF-alpha subunits for ubiquitin-mediated proteolysis. To provide further insights into these processes we constructed Chinese hamster ovary (CHO) cells bearing stably integrated plasmids that expressed HRE-linked surface antigens and used these cells in genetic screens for mutants that demonstrated constitutive up-regulation of HRE activity. From mutagenized cultures, clones were isolated that demonstrated up-regulation of HRE activity and increased HIF-1alpha protein levels in normoxic culture. Transfection and cell fusion studies suggested that these cells possess recessive defects that affect one or more pathways involved in HIF-alpha proteolysis. Two lines were demonstrated to harbor truncating mutations in the von Hippel-Lindau (VHL) tumor suppressor gene. In these cells, defects in ubiquitylation of exogenous human HIF-1alpha in vitro could be complemented by wild type pVHL, and re-expression of a wild type VHL gene restored a normal pattern of HIF/HRE activity, demonstrating the critical dependence of HIF regulation on pVHL in CHO cells. In contrast, other mutant cells had no demonstrable mutation in the VHL gene, and ubiquitylated exogenous HIF-1alpha normally, suggesting that they contain defects at other points in the oxygen-regulated processing of HIF-alpha subunits.


Subject(s)
DNA-Binding Proteins/physiology , Gene Expression Regulation/physiology , Genes, Tumor Suppressor , Ligases/genetics , Tumor Suppressor Proteins , Ubiquitin-Protein Ligases , von Hippel-Lindau Disease/genetics , Animals , Base Sequence , CHO Cells , Cell Fusion , Clone Cells , Cricetinae , DNA , Flow Cytometry , Genetic Complementation Test , Hydrolysis , Mice , Molecular Sequence Data , Mutation , Von Hippel-Lindau Tumor Suppressor Protein
3.
Kidney Int ; 52(3): 715-24, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9291192

ABSTRACT

To define the potential for erythropoietin gene expression in injured kidneys, marker gene expression was examined in transgenic mice bearing a homologously recombined erythropoietin--simian virus 40 T antigen (Epo-TAg) transgene. Three types of renal injury were studied: ureteric obstruction, global ischemia following clamping of the renal pedicle, and focal needlestick injury. All modes of injury were associated with an expansion of the interstitial space, which contained an increased number of cells. Alterations observed in the interstitial fibroblast-like cells included an increased number and complexity of cellular processes, enhanced expression of contractile elements, particularly of the intermediate filament desmin, and reduced expression of ecto-5'-nucleotidase. Following each type of injury there was a focal or general reduction in the proportion of such cells that could be stimulated to express Epo-TAg. However, some positively staining cells were present even in severely injured regions and more could be recruited to express Epo-TAg by severe anemic or hypoxic stimulation, indicating that cells with the potential for erythropoietin gene expression were neither absent nor completely refractory to stimulation in these regions. In all injured kidneys, Epo-TAg expression was limited to the fibroblast-like population. Double labeling experiments showed that cells expressing Epo-TAg also expressed increased amounts of desmin, demonstrating that the myofibroblast features which develop in response to injury and the capacity for erythropoietin gene expression are not mutually exclusive.


Subject(s)
Kidney Diseases/pathology , Kidney/injuries , Kidney/pathology , Animals , Antigens/analysis , Antigens, Viral, Tumor/genetics , Erythropoietin/genetics , Fibroblasts/physiology , Gene Expression , Ischemia/pathology , Kidney/immunology , Kidney Diseases/genetics , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Transgenic , Microscopy, Electron , Needlestick Injuries/pathology , Phenotype , Renal Circulation , Simian virus 40/genetics , Simian virus 40/immunology , Ureteral Obstruction/pathology
4.
Proc Natl Acad Sci U S A ; 94(15): 8104-9, 1997 Jul 22.
Article in English | MEDLINE | ID: mdl-9223322

ABSTRACT

Recent studies of tissue culture cells have defined a widespread system of oxygen-regulated gene expression based on the activation of a heterodimeric transcription factor termed hypoxia-inducible factor-1 (HIF-1). To determine whether the HIF-1 transcriptional response is activated within solid tumors and to define the consequences, we have studied tumor xenografts of a set of hepatoma (Hepa-1) cells that are wild type (wt), deficient (c4), and revertant (Rc4) for an obligatory component of the HIF-1 heterodimer, HIF-1beta. Because HIF-1beta is also essential for the xenobiotic response (in which it is termed the aryl hydrocarbon receptor nuclear translocator), we also studied c31 cells, which have a different defect in the xenobiotic response and form the HIF-1 complex normally. Two genes that show different degrees of HIF-1-dependent hypoxia-inducible expression in cell culture were selected for analysis-the glucose transporter, GLUT3, and vascular endothelial growth factor (VEGF). In situ hybridization showed intense focal induction of gene expression in tumors derived from wt, Rc4, and c31 cells, which was reduced (VEGF) or not seen (GLUT3) in those derived from c4 cells. In association with these changes, tumors of c4 cells had reduced vascularity and grew more slowly. These findings show that HIF-1 activation occurs in hypoxic regions of tumors and demonstrate a major influence on gene expression, tumor angiogenesis, and growth.


Subject(s)
Carcinoma, Hepatocellular/blood supply , Carcinoma, Hepatocellular/pathology , DNA-Binding Proteins/metabolism , Gene Expression Regulation, Neoplastic , Liver Neoplasms/blood supply , Liver Neoplasms/pathology , Nuclear Proteins/metabolism , Animals , Cell Division , Cell Line , Hypoxia-Inducible Factor 1 , Hypoxia-Inducible Factor 1, alpha Subunit , Mice , Mice, Nude , Necrosis , Neoplasm Transplantation , Neovascularization, Pathologic , Transcription Factors/metabolism
7.
Kidney Int ; 44(5): 1149-62, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8264149

ABSTRACT

Regulation of erythropoietin production by the kidneys is central to the control of erythropoiesis. Uncertainty about the identity of the renal cells involved has been a major obstacle to understanding this mechanism. We have used sequence from the mouse erythropoietin locus to direct expression of a marker gene, SV40 T antigen, to these cells in transgenic mice. The transgenic constructs contained an oligonucleotide marker (Epo-M) or SV40 sequence (Epo-TAg) in the 5' untranslated region of the mouse erythropoietin gene, flanked on each side by 9 and 7.5 kb of DNA from the mouse erythropoietin locus. Anemia-inducible expression of Epo-M and Epo-TAg was observed in the kidney. In one of thirteen lines, homologous integration of Epo-TAg into the mouse erythropoietin locus occurred. In transgenic mice bearing Epo-TAg at homologous and heterologous insertion sites, renal expression was restricted to a population of cells in the interstitium of the cortex and outer medulla. Immunohistochemical characterization by light and electron microscopy shows that these are the fibroblast-like type I interstitial cells.


Subject(s)
Erythropoietin/metabolism , Kidney/metabolism , Animals , Antigens, Polyomavirus Transforming/genetics , Antigens, Polyomavirus Transforming/metabolism , Erythropoietin/genetics , Genetic Markers , Immunohistochemistry , Kidney/cytology , Mice , Mice, Transgenic , Microscopy, Immunoelectron , Oligonucleotides/genetics , RNA, Messenger/analysis , Tissue Distribution
8.
J Exp Med ; 172(2): 657-60, 1990 Aug 01.
Article in English | MEDLINE | ID: mdl-2373996

ABSTRACT

Using oligonucleotide primers complementary to conserved regions in the mouse erythropoietin (Epo) gene, a portion of the rat Epo gene was amplified by the polymerase chain reaction to produce a probe suitable for assay of rat Epo mRNA by RNAse protection. The assay, which has sufficient sensitivity to measure to Epo mRNA in unstimulated rat kidneys, was used to demonstrate high amplitude in vitro modulation of Epo mRNA levels in response to changes in perfusate flow rate and oxygen tension in isolated kidneys, thus providing clear evidence that all the necessary events linking changes in oxygen delivery to the modulation of Epo mRNA levels can occur intrarenally.


Subject(s)
Erythropoietin/genetics , Gene Expression Regulation/drug effects , Kidney/metabolism , Oxygen/pharmacology , RNA, Messenger/genetics , Animals , In Vitro Techniques , Male , Oligonucleotide Probes , Partial Pressure , Perfusion , Polymerase Chain Reaction/methods , RNA, Messenger/metabolism , Rats , Rats, Inbred Strains , Ribonucleases , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...